Dr. Dalal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St
Boston, MA 02115- Is this information wrong?
Summary
- Dr. Rahul Dalal is a gastroenterologist in Boston, MA and is affiliated with Brigham and Women's Hospital. He received his medical degree from The Warren Alpert Medical School of Brown University and has been in practice 2 years. He also speaks multiple languages, including Spanish. He specializes in inflammatory bowel disease and is experienced in general internal medicine and gastroenterology.
Education & Training
- Harvard TH Chan School of Public HealthMPH, Clinical Effectivenesss, 2020 - 2022
- Brigham and Women's HospitalFellowship, Gastroenterology, 2019 - 2022
- University of PennsylvaniaCertificate, Healthcare Quality Improvement and Patient Safety, 2018 - 2019
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2015 - 2018
- The Warren Alpert Medical School of Brown UniversityClass of 2015
- Yale UniversityBS, Molecular Biophysics and Biochemistry, Magna Cum Laude, 2007 - 2011
Certifications & Licensure
- MA State Medical License 2019 - 2025
- PA State Medical License 2015 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- AOA Inductee Alpha Omega Alpha Honor Medical Society
- T32 DK007533 NIH, 2020
- Fellows-in-Training Award (IBD) American College of Gastroenterology, 2020
- Join now to see all
Publications & Presentations
PubMed
- Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab for Inflammatory Bowel Disease and Recurrent C . difficile Infection.Jessica R Allegretti, Jordan Axelrad, Rahul S Dalal, Colleen R Kelly, Ari Grinspan, Monika Fischer> ;The American Journal of Gastroenterology. 2024 Mar 19
- One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study.Rahul S Dalal, Govind Kallumkal, Heidy J Cabral, Edward L Barnes, Jessica R Allegretti> ;The American Journal of Gastroenterology. 2024 Apr 1
- Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States.Rahul S Dalal, Rachel W Winter, Sanchit Gupta, Gila F Sasson, Matthew J Hamilton, Jessica R Allegretti> ;Inflammatory Bowel Diseases. 2024 Feb 26
- Join now to see all
Books/Book Chapters
Lectures
- Predictors of ustekinumab failure after dose intensification among patients with Crohn’s diseaseAmerican College of Gastroenterology Annual Scientific Meeting (Virtual) - 10/26/2020
- Pre-admission cannabis use is positively correlated with inpatient opioid dose exposure in hospitalized patients with inflammatory bowel diseasesNorth American Conference of Gastroenterology Fellows, American College of Gastroenterology - 3/2020
- A multimodal intervention reduces intravenous opioid exposure among hospitalized patients with inflammatory bowel diseaseAmerican College of Gastroenterology Annual Scientific Meeting - 10/29/2019
- Join now to see all
Other
- Linking Strain Engraftment in FMT With Maintenance of Remission in Crohn's DiseaseDalal, R
https://www.practiceupdate.com/content/linking-strain-engraftment-in-fmt-with-maintenance-of-remission-in-crohns-disease/112749/12/9/1
Practice Update, Gastroenterology - 2/2/2021 - Preparing for Clerkships: Learning to Deliver Specialty-Specific Oral PresentationsDaniel M, Heney R, Kwan B, Mannino C, Williams C, Macdonald K, Williams J, Reardon J, Resnick-Ault D, Schaetzel-Hill T, Cormier J, Schwede M, Sangal R, Dalal R, George..., MedEdPORTAL Publications
https://www.mededportal.org/publication/10261
10/29/2015 - First Aid Step 1 Flash Facts 2013, Biochemistry and Renal SectionsDalal R
https://www.usmle-rx.com/content/step-1-flash-facts
1/1/2013
Press Mentions
- Vedolizumab Doesn’t Increase Risk of C Diff in Ulcerative ColitisDecember 28th, 2021
- Multimodal Intervention Reduces Opioid Use in Hospitalized Patients with IBDNovember 11th, 2019
- Hospital Teaching Status Not a Factor in IBD Treatment CostsMay 2nd, 2019
- Join now to see all
Grant Support
- Makrauer IBD FundBrigham and Women's Hospital2020–2022
- T32National Institute of Diabetes and Digestive and Kidney Diseases2020–2021
- T35National Heart, Lung, and Blood Institute2012–2013
Professional Memberships
- Member
- Member
- Member
- Sigma Xi Scientific Research Honor SocietyAssociate Member
- Member
- Member
Other Languages
- Spanish
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: